These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity. Miro JM; Cervera C; Garcia-de-la-Maria C; Del Rio A; Armero Y; Mestres CA; Grau JM; Marco F; Moreno A Scand J Infect Dis; 2008; 40(11-12):968-72. PubMed ID: 18767002 [TBL] [Abstract][Full Text] [Related]
4. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone. Pericas JM; Cervera C; del Rio A; Moreno A; Garcia de la Maria C; Almela M; Falces C; Ninot S; Castañeda X; Armero Y; Soy D; Gatell JM; Marco F; Mestres CA; Miro JM; Clin Microbiol Infect; 2014 Dec; 20(12):O1075-83. PubMed ID: 25040215 [TBL] [Abstract][Full Text] [Related]
5. [Active infective endocarditis remaining latent for six weeks after discontinuation of antibiotic therapy: a case report]. Masuoka A; Imanaka K; Sugie M; Ogiwara M; Nishimura M; Kato M; Asano H; Kuboi K; Yamada Y; Nishimura S; Kyo S J Cardiol; 2005 Dec; 46(6):243-7. PubMed ID: 16389744 [TBL] [Abstract][Full Text] [Related]
6. Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis. Luque-Paz D; Cuervo G; Miró JM; Tattevin P Clin Microbiol Infect; 2023 Jun; 29(6):676-678. PubMed ID: 36889644 [No Abstract] [Full Text] [Related]
7. Comparison of Dual β-Lactam therapy to penicillin-aminoglycoside combination in treatment of Enterococcus faecalis infective endocarditis. El Rafei A; DeSimone DC; Narichania AD; Sohail MR; Vikram HR; Li Z; Steckelberg JM; Wilson WR; Baddour LM J Infect; 2018 Nov; 77(5):398-404. PubMed ID: 29969596 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the "ex vivo" synergism method. Tascini C; Doria R; Leonildi A; Martinelli C; Menichetti F J Chemother; 2004 Aug; 16(4):400-3. PubMed ID: 15332717 [TBL] [Abstract][Full Text] [Related]
10. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis. Fernández-Hidalgo N; Almirante B; Gavaldà J; Gurgui M; Peña C; de Alarcón A; Ruiz J; Vilacosta I; Montejo M; Vallejo N; López-Medrano F; Plata A; López J; Hidalgo-Tenorio C; Gálvez J; Sáez C; Lomas JM; Falcone M; de la Torre J; Martínez-Lacasa X; Pahissa A Clin Infect Dis; 2013 May; 56(9):1261-8. PubMed ID: 23392394 [TBL] [Abstract][Full Text] [Related]
11. A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis. Beganovic M; Luther MK; Rice LB; Arias CA; Rybak MJ; LaPlante KL Clin Infect Dis; 2018 Jul; 67(2):303-309. PubMed ID: 29390132 [TBL] [Abstract][Full Text] [Related]
12. Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates. Westbrook KJ; Chilambi GS; Stellfox ME; Nordstrom HR; Li Y; Iovleva A; Shah NH; Jones CE; Kline EG; Squires KM; Miller WR; Tran TT; Arias CA; Doi Y; Shields RK; Van Tyne D J Antimicrob Chemother; 2024 Apr; 79(4):801-809. PubMed ID: 38334390 [TBL] [Abstract][Full Text] [Related]
13. Gentamicin once-daily in enterococcal endocarditis. Bassetti M; Righi E; Crapis M; Cojutti P; Venturini S; Viale P; Pea F Int J Cardiol; 2013 Oct; 168(5):5033-4. PubMed ID: 23931973 [No Abstract] [Full Text] [Related]
14. Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study. Ramos-Martínez A; Pericàs JM; Fernández-Cruz A; Muñoz P; Valerio M; Kestler M; Montejo M; Fariñas MC; Sousa D; Domínguez F; Ojeda-Burgos G; Plata A; Vidal L; Miró JM; PLoS One; 2020; 15(8):e0237011. PubMed ID: 32745091 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of ampicillin plus ceftriaxone compared to ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis: a noninferiority question not yet properly investigated. Solla DJ Clin Infect Dis; 2013 Sep; 57(5):768. PubMed ID: 23704125 [No Abstract] [Full Text] [Related]
16. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis. Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM; J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495 [TBL] [Abstract][Full Text] [Related]
17. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Gavaldà J; Len O; Miró JM; Muñoz P; Montejo M; Alarcón A; de la Torre-Cisneros J; Peña C; Martínez-Lacasa X; Sarria C; Bou G; Aguado JM; Navas E; Romeu J; Marco F; Torres C; Tornos P; Planes A; Falcó V; Almirante B; Pahissa A Ann Intern Med; 2007 Apr; 146(8):574-9. PubMed ID: 17438316 [TBL] [Abstract][Full Text] [Related]
18. Ampicillin plus ceftriaxone for high-level aminoglycoside-resistant Enterococcus faecalis endocarditis. Singh A Ann Intern Med; 2008 Feb; 148(3):243; author reply 243. PubMed ID: 18252687 [No Abstract] [Full Text] [Related]
19. [Enterococcus faecalis endocarditis successfully treated with daptomycin]. Bonnet E Med Mal Infect; 2008 Dec; 38 Spec No 2():4-6. PubMed ID: 19185201 [No Abstract] [Full Text] [Related]